16.06.2021 • NewsNouryon

Nouryon in Sodium Chlorate Deal with Metsä Fibre

Dutch specialty chemicals company Nouryon has signed a 10-year agreement with Finland’s Metsä Fibre, a major producer of bioproducts, biochemicals and bioenergy, to supply sodium chlorate.

Metsa Fibre will use the sodium chlorate in its new €1.6 billion bioproducts mill in Kemi, Finland, that is currently under construction and scheduled to start up in the third quarter of 2023.

As part of the deal, Nouryon will expand and upgrade its facility in Oulo, Finland, to manufacture sodium chlorate using renewable energy.

Johan Landfors, Nouryon’s executive vice president and president, technology solutions and Europe, commented: “Our strategy is to continue expanding in the renewable fibers market, which is an important part of the packaging and tissue markets, by delivering essential specialty chemicals solutions that our customers, such as Metsä Fibre, clearly need.”

Author: Elaine Burridge, Freelance Journalist

Nouryon has signed a 10-year agreement with Finland’s Metsä Fibre, a major...
Nouryon has signed a 10-year agreement with Finland’s Metsä Fibre, a major producer of bioproducts, biochemicals and bioenergy, to supply sodium chlorate. Under the deal, Nouryon will expand and upgrade its plant in Oulo, Finland, to make sodium chlorate using renewable energy. (c) Metsä Fibre

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.